Cents and Sensibility - Kimberly and Friends' Consortium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kimberly Lee who wrote ()	1/10/2000 11:33:00 AM
From: Shadowed	of 108040

From briefing.com: 10:25 ET Maxygen (MAXY) 63 3/8 +6 1/16 (+10.5%): Robertson Stephens initiates coverage of recent IPO with a "buy" rating and $108 target price; calls MAXY a "must-own", core holding in the genomics sector with potential returns similar to those of Affymetrix (AFFX 172 +18 3/4) and Millennium (MLNM 160 1/8 +8 1/4). Firm also raising target price on AFFX.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next